Internal Medicine, Endocrinology, Diabetes, & Metabolism · Naples, FL
NPI
1386738680
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
9010 Strada Stell Ct, Suite 203
Naples, FL, 34109
Phone (239) 254-1316
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
60,590 services
Medicare patients, 2024
1,636
Average age 76
Drug cost, 2024
$4.0M
9,034 prescriptions
Company payments, 2025
$2,379
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vita Anksh was code J0897 (injection, denosumab, 1 mg), 30,060 times for 310 patients. In total Vita Anksh billed 60,590 services in 20 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 30,060 | 310 | $20.42 | $614K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 20,160 | 21 | $8.58 | $173K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 3,431 | 1,465 | $13.91 | $48K |
| 99214 Office E&M - Established | Office | 2,374 | 1,130 | $99.84 | $237K |
| 99212 Office E&M - Established | Office | 836 | 283 | $46.59 | $39K |
| 99454 E&M - Miscellaneous | Office | 780 | 274 | $38.15 | $30K |
| 99213 Office E&M - Established | Office | 723 | 499 | $68.37 | $49K |
| 96401 Chemotherapy Administration | Office | 605 | 325 | $60.08 | $36K |
| 99215 Office E&M - Established | Office | 363 | 235 | $146.61 | $53K |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 274 | 215 | $42.04 | $12K |
| 95250 Test - Miscellaneous | Office | 207 | 182 | $113.36 | $23K |
| 77080 Standard X-ray | Office | 190 | 190 | $40.96 | $7,782 |
| 99204 Office E&M - New | Office | 168 | 168 | $129.60 | $22K |
| 76536 Ultrasound - Nonspecific | Office | 165 | 163 | $87.90 | $15K |
| 99203 Office E&M - New | Office | 104 | 104 | $78.91 | $8,207 |
By year: 2022 $957K for 49,229 services; 2023 $1.1M for 44,343 services; 2024 $1.4M for 60,590 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vita Anksh prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 1,206 prescriptions and refills. In total Vita Anksh wrote 9,034 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 1,206 | 1,450 | 203 | $1.5M |
| Levothyroxine Sodium Generic | 934 | 2,681 | 286 | $12K |
| Rosuvastatin Calcium Generic | 664 | 1,956 | 216 | $12K |
| Synthroid Levothyroxine Sodium | 509 | 1,385 | 146 | $53K |
| Ozempic Semaglutide | 270 | 426 | 72 | $375K |
| Metformin Hcl Generic | 249 | 725 | 85 | $2,013 |
| Losartan Potassium Generic | 249 | 727 | 80 | $2,807 |
| Jardiance Empagliflozin | 183 | 459 | 56 | $241K |
| Atorvastatin Calcium Generic | 173 | 471 | 56 | $1,982 |
| Ezetimibe Generic | 172 | 503 | 61 | $7,875 |
| Metformin Hcl Er Metformin Hcl | 166 | 460 | 58 | $2,051 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 145 | 387 | 59 | $19K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 139 | 290 | 36 | $222K |
| Tresiba Flextouch U-100 Insulin Degludec | 137 | 302 | 50 | $78K |
| Amlodipine Besylate Generic | 119 | 315 | 39 | $1,137 |
Brand drugs: 4,605 claims; generic drugs: 4,011 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vita Anksh $2,379 ($2,379 in general payments such as food, travel and fees) from 27 companies. The largest payer was Novo Nordisk Inc with $277.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 15 | $277 |
| Amgen Inc. AMGN | 16 | $276 |
| Corcept Therapeutics CORT | 17 | $246 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $228 |
| Almatica Pharma LLC | 8 | $167 |
| Xeris Pharmaceuticals, Inc. | 6 | $127 |
| Lilly USA, LLC LLY | 7 | $125 |
| Abbvie Inc. ABBV | 5 | $117 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $89.7 |
| Tandem Diabetes Care, Inc. TNDM | 6 | $87.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.